Recent studies manifested that mTOR inhibitor rapamycin improved mitochondrial dysfunction via lupus-prone mice (Oaks et al., 2016) and inhibits apoptosis by activating mitophagy in spinal ischemia–reperfusion injury (Li et al., 2018). Here, MTOR is linked to systemic lupus erythematosus.